UPPSALA, SWEDEN / ACCESSWIRE / May 21, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) In a new clinical study published in the high-impact Anesthesiology journal, a team of US-based researchers compared the accuracy
Estimating the prevalence, characteristics of SAS and variation in AHI three months after severe COVID-19 requiring intensive care unit (ICU) admission.